Back to search
FDAFDA · Food and drugs·Recall number D-0071-2019

CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate 5%, octocrylene 10%, Net Wt. 0.15 oz. (4.25 g) stick, CeraVe LLC., New York, NY 10001, UPC 3 01872 49201 7.

Published October 24, 2018 · Recall initiated: August 3, 2018

Summary

FDA records drug Class II recall D-0071-2019, published October 24, 2018 and initiated August 3, 2018. Recalling firm: Product Quest Manufacturing LLC; Status: Terminated; Reported quantity: 25,596 sticks; Lot: Lot: PSP85W/172792H. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Product Quest Manufacturing LLC
Distributor
Nationwide in the USA
Lot
Lot: PSP85W/172792H
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CeraVe Healing Lip Balm/SPF 30 (avobenzone 3%, dimethicone 1%, homosalate 10%, octisalate 5%, octocrylene 10%, Net Wt. 0.15 oz. (4.25 g) stick, CeraVe LLC., New York, NY 10001, UPC 3 01872 49201 7. recalled?

Yes. FDA published recall D-0071-2019 on October 24, 2018. Reported hazard: Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus.

What should I do if I have this product?

Voluntary: Firm initiated · Letter